Discover. Connect. Capitalize.

Expert View

131 Profile Views - 679 Project Views

Share

John Reid Wingard
Price Eminent Scholar, Deputy Director of Research & Director of Bone Marrow Transplant Program

University of Florida

Connect

Search

Google or Google Scholar for John Wingard

Recent Publications:

1.        Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather H, Confer DL, Maziarz RT, Stadtmauer EA, Bolanos-Meade J, Brown J, DiPersio JF, Boeckh M, and Marr KA. Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allogeneic Hematopoietic Cell Transplantation.  Blood, 2010; Dec 9;116(24):5111-8.

2.        Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MH, and Pavletic SZ.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.  Blood 2011; June 16; 117(24):  6714-6720.

3.        Bishop MM, Curbow BA, Springer S, Lee J, Wingard JR.  Comparison of Lasting Life Changes after Cancer and BMT:  Perspectives of Long-Term Survivors and Spouses.  Psycho-Oncology Psycho - Oncology 2011;(20)9:926-934.

4.        Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O’Donnell PV.  Alternative donor transplantation:  results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood grafts.  Blood, 2011; 118(2):  282-288.

5.        Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter P, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H, Shih YT, Gale RP, Wingard JR, Appelbaum FR, Anasetti C.  Generic immunosuppressants in hematopoietic cell transplantation.  Biol Blood Marrow Transplant 2011 Mar;17(3):285-90.

6.        Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JH, Wingard JR.  Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer:  2010 update by the Infectious Diseases Society of America.  Clin Infect Dis, 2011 Feb;52(4):427-431 and e56-93.

7.        Jacobsohn DA, Arora M, Klein JP, Hassebroek AM, Flowers MED, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn J-Y, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ.  Risk factors associated with increased non-relapse mortality and with poor overall survival in children with chronic graft-versus-host disease.  Blood 2011  Oct 20;118(16):4472-9. PMID 21878671

8.        Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sanchez de Todedo J, Ferster A, Szabocs P, Wingard JR, Horwitz E, Filipovich AH.  Malignancies after hematopoietic cell transplantation for primary immune deficiencies:  a report from the Center for International Blood and Marrow Transplant Research.  Biol Blood Marrow Transplant, 2011; 17(12):  1783-1789.

9.        Loren AS, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Gupta V, Hale GA, Marks AI, Stadtmauer E, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani B, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS.  Pregnancy After Hematopoietic-cell Transplantation: A Report From the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).  Biol Blood Marr Transplant, 2011 Feb;17(2):157-66.

10.    Majhail NS, Brazauskas R, Rizzo JD, Sobecks R, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G, for the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research.  Secondary solid cancers after allogeneic hematopoietic-cell transplantation using busulfan-cyclophosphamide conditioning. Blood, 2011; 117(1):316-322.

11.    Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, Wheat LJ, Wingard JR.  Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.  Biol Blood Marrow Transplant 2011; 17(7): 1043-1050.

12.    Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito J, Kauffman CA, Lyon M, Marr KA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Walsh TJ, Wingard JR, Kontoyiannis DP.  Epidemiology, Incidence, and Trends of Zygomycetes, Fusarium, and Scedosporium Invasive Infections in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: Results from TRANSNET, 2001-2006.  Emerging Infectious Diseases, 2011; 17(10):1855-64. PMID: 22000355

13.    Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Anders F, Lo Nigro LL, Ayas M, Purtill D, Bourdjedir K, Chaves W, Walters M, Wagner J, Gluckman E, Rocha V.  Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.   Biol Blood Marrow Transplant, 2011 Sep;17(9):1375-82.

14.    Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Hematol Oncol Clin North Am. 2011 Feb;25(1):101-16.

15.    Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Bolwell B, Armenian S, Baker KS, Di Bartolomeo P, Bhatia S, Burns LJ, Cahn JY, Chen J, Eapen M, Gajewski JL, Gupta V, Hale GA, Halter J, Horowitz MM, Jakubowski AA, Kolb HJ, Hayes-Lattin BM, Lazarus HM, Loren AW, Marks DI, Reddy V, Schouten HC, Tichelli A, Warwick AB, Wood WA, Bolwell B, Rizzo JD, Socié G,  Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.  J Clin Oncol, 2011:  29 (16):  2230-2239.

16.    Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, Lemaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS.  Relationship of Race/Ethnicity and Survival after Single Umbilical Cord Blood Transplantation for Adults and Children with Leukemia and Myelodysplastic Syndromes.  Biol Blood Marrow Transplant. 2011 Nov 4. [Epub ahead of print].  PMID:22062801

17.    Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail K, Sumrall T, Wingard JR, Theriaque D, Shuster JJ, Atkinson MA, Schatz DA.  Autologous umbilical cord blood transfusion in young children with type 1 diabetes increases regulatory T cells but fails to preserve C-peptide.  Diabetes Care 2011;  2011 Dec;34(12):2567-9. PMID:22011412

18.    Wirk B, Wingard JR.  Assessing responses to treatment of opportunistic mycoses and salvage strategies.  Current Infectious Disease Reports 2011 Dec;13(6):492-503.PMID:21948189

19.    Carilli AR, Sugrue MW, Rosenau E, Chang M, Fisk D, Medie-Hill M, Williams K, Wiggins L, Wingard JR.  African American adult apheresis donors respond to granulocyte-colony stimulating factor with neutrophil and progenitor yields comparable to Caucasian and Hispanic donors.  Transfusion, 2012 Jan Volume 52(1): 166–172. PMID: 21790625.

20.    Norkin M, Hsu JW, Wingard JR.  Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantaion.    Sem Hematol 2012 Jan. 49(1): 104-109.

21.    Wingard JR, Elderjou L, Leather H.  Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.  Curr Opin Hematol 2012;  Jan;19(1):21-6. PMID:22080847

© 1999-2023, State of Florida